Regional Analysis
Global Non-Invasive Blood Glucose Monitoring Devices Market Regional Insights
- North America is the largest market for non-invasive blood glucose monitoring devices, accounting for 35% of the global market share for the year 2023. The high prevalence of diabetes in the region is driving the growth of the market.
- Europe is the second largest market for non-invasive blood glucose monitoring devices, accounting for 25% of the global market share for the year 2023. The increasing awareness in the region is driving the market for the forecasted period of time
- Asia Pacific is the third largest market for non-invasive blood glucose monitoring devices, accounting for 20% of the global market share for the year 2023. The rising incidence of heart diseases and lifestyle related diseases such as diabetes in the region are driving the growth of the market.
Figure 1. Global Non-Invasive Blood Glucose Monitoring Devices Market Share (%), by Region, 2023
![](/images/research-%20methodology/non-invasive-blood-glucose-monitoring-devices-market-figure-1.webp)
Geographies covered:
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC Countries, Israel, and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa